|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 107, Issue 9 2459-2469, Copyright © 1994 by Company of Biologists
JOURNAL ARTICLES |
PA Campochiaro, SF Hackett, SA Vinores, J Freund, C Csaky, W LaRochelle, J Henderer, M Johnson, IR Rodriguez, Z Friedman and al. et
Wilmer Institute, Johns Hopkins Hospital, Baltimore, MD 21287-9277.
The retinal pigmented epithelium (RPE) plays a major role in normal and exaggerated retinal wound repair; the latter can result in epiretinal membrane formation and loss of vision. The RPE forms a stable monolayer of highly differentiated cells that proliferates only during wound repair. The mechanism underlying the change to the proliferating phenotype is unknown. When grown on a plastic substratum, cultured RPE cells mimic the proliferating phenotype in situ; they escape density arrest and proliferate in serum-free medium. In this study, we have demonstrated that a platelet-derived growth factor (PDGF) autocrine loop is involved in RPE growth in serum-free medium, because: (1) RPE cells secrete PDGF into their media and express PDGF receptors; (2) the PDGF receptors on RPE cells are autophosphorylated in serum-free medium and suramin, an agent that displaces PDGF and other growth factors from their receptors, blocks the autophosphorylation; and (3) a neutralizing antibody to PDGF significantly decreases RPE growth in serum-free medium. When a linear scrape is made in an RPE monolayer, the cells migrate and proliferate to fill in the gap mimicking wound repair in situ. Cells along the edge of the scrape show increased expression of PDGF and PDGF-beta receptors, and increased staining for proliferating cell nuclear antigen. Immunohistochemistry and in situ hybridization demonstrate expression of PDGF in ganglion cells and cells of retinal blood vessels. PDGF is not detected in the outer retina or RPE in untreated eyes, but is detected in RPE participating in wound repair, either adjacent to laser burns or underlying retinal detachment. PDGF and PDGF receptors are also expressed in RPE in epiretinal membranes removed during vitreous surgery. These data suggest that PDGF is an autocrine stimulator of growth in RPE that plays a role in retinal wound repair and epiretinal membrane formation.
This article has been cited by other articles:
|
|
 |
|
  S. K. Biswas, Y. Zhao, A. Nagalingam, T. W. Gardner, and L. Sandirasegarane PDGF- and Insulin/IGF-1-Specific Distinct Modes of Class IA PI 3-Kinase Activation in Normal Rat Retinas and RGC-5 Retinal Ganglion Cells Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3687 - 3698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lei, G. Velez, P. Hovland, T. Hirose, and A. Kazlauskas Plasmin Is the Major Protease Responsible for Processing PDGF-C in the Vitreous of Patients with Proliferative Vitreoretinopathy Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 42 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Li, A. Maminishkis, F. E. Wang, and S. S. Miller PDGF-C and -D Induced Proliferation/Migration of Human RPE Is Abolished by Inflammatory Cytokines Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5722 - 5732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lei, P. Hovland, G. Velez, A. Haran, D. Gilbertson, T. Hirose, and A. Kazlauskas A Potential Role for PDGF-C in Experimental and Clinical Proliferative Vitreoretinopathy Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2335 - 2342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Chen and Z.-Z. Ma N-Cadherin Expression in a Rat Model of Retinal Detachment and Reattachment Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1832 - 1838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mukherjee and C. Guidry The Insulin-Like Growth Factor System Modulates Retinal Pigment Epithelial Cell Tractional Force Generation Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1892 - 1899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Strauss The Retinal Pigment Epithelium in Visual Function Physiol Rev, July 1, 2005; 85(3): 845 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hirayama, Y. Hata, Y. Noda, M. Miura, I. Yamanaka, H. Shimokawa, and T. Ishibashi The Involvement of the Rho-Kinase Pathway and Its Regulation in Cytokine-Induced Collagen Gel Contraction by Hyalocytes Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 3896 - 3903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Saishin, Y. Saishin, K. Takahashi, M.-S. Seo, M. Melia, and P. A. Campochiaro The Kinase Inhibitor PKC412 Suppresses Epiretinal Membrane Formation and Retinal Detachment in Mice with Proliferative Retinopathies Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3656 - 3662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, Y. Ninomiya, I. K. Sugino, and M. A. Zarbin Retinal Pigment Epithelium Wound Healing in Human Bruch's Membrane Explants Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2199 - 2210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Chaum and H. Yang Transgenic Expression of IGF-1 Modifies the Proliferative Potential of Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3758 - 3764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Hogg, I. Grierson, and P. Hiscott Direct Comparison of the Migration of Three Cell Types Involved in Epiretinal Membrane Formation Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2749 - 2757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ikuno and A. Kazlauskas An In Vivo Gene Therapy Approach for Experimental Proliferative Vitreoretinopathy Using the Truncated Platelet-Derived Growth Factor {alpha} Receptor Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2406 - 2411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mori, P. Gehlbach, A. Ando, G. Dyer, E. Lipinsky, A. G. Chaudhry, S. F. Hackett, and P. A. Campochiaro Retina-Specific Expression of PDGF-B Versus PDGF-A: Vascular Versus Nonvascular Proliferative Retinopathy Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 2001 - 2006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. DeWitt, J. Y. Dong, H. S. Wiley, and D. A. Lauffenburger Quantitative analysis of the EGF receptor autocrine system reveals cryptic regulation of cell response by ligand capture J. Cell Sci., March 8, 2002; 114(12): 2301 - 2313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ikuno and A. Kazlauskas TGF{beta}1-Dependent Contraction of Fibroblasts Is Mediated by the PDGF{alpha} Receptor Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 41 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Geisert Jr, H. J. Abel, L. Fan, and G. R. Geisert Retinal Pigment Epithelium of the Rat Express CD81, the Target of the Anti-proliferative Antibody (TAPA) Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 274 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Matsui, L.-R. Lin, D. P. Singh, T. Shinohara, and V. N. Reddy Lens Epithelium-Derived Growth Factor: Increased Survival and Decreased DNA Breakage of Human RPE Cells Induced by Oxidative Stress Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2935 - 2941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yamada, E. Yamada, A. Ando, N. Esumi, N. Bora, J. Saikia, C.-H. Sung, D. J. Zack, and P. A. Campochiaro Fibroblast Growth Factor-2 Decreases Hyperoxia-Induced Photoreceptor Cell Death in Mice Am. J. Pathol., September 1, 2001; 159(3): 1113 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sakagami, T. Kodama, and D. G. Puro PDGF-Induced Coupling of Function with Metabolism in Microvascular Pericytes of the Retina Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1939 - 1944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. ROSENTHAL, H. THIEME, and O. STRAUSS Fibroblast growth factor receptor 2 (FGFR2) in brain neurons and retinal pigment epithelial cells act via stimulation of neuroendocrine L-type channels (Cav1.3) FASEB J, April 1, 2001; 15(6): 970 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ando, M. Ueda, M. Uyama, Y. Masu, and S. Ito Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor Br. J. Ophthalmol., November 1, 2000; 84(11): 1306 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ikuno, F.-L. Leong, and A. Kazlauskas Attenuation of Experimental Proliferative Vitreoretinopathy by Inhibiting the Platelet-Derived Growth Factor Receptor Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3107 - 3116. [Abstract] [Full Text]
|
|
|
|
|
|
M. Kaida, F. Cao, C. M. B. Skumatz, P. E. Irving, and J. M. Burke Time at Confluence for Human RPE Cells: Effects on the Adherens Junction and In Vitro Wound Closure Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3215 - 3224. [Abstract] [Full Text]
|
|
|
|
|
|
M. S. Seo, N. Okamoto, M. A. Vinores, S. A. Vinores, S. F. Hackett, H. Yamada, E. Yamada, N. L. Derevjanik, W. LaRochelle, D. J. Zack, et al. Photoreceptor-Specific Expression of Platelet-Derived Growth Factor-B Results in Traction Retinal Detachment Am. J. Pathol., September 1, 2000; 157(3): 995 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Carrington, D. McLeod, and M. Boulton IL-10 and Antibodies to TGF-{beta}2 and PDGF Inhibit RPE-Mediated Retinal Contraction Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1210 - 1216. [Abstract] [Full Text]
|
|
|
|
|
|
I. Mamballikalathil, C. Mann, and C. Guidry Tractional Force Generation by Porcine Muller Cells: Paracrine Stimulation by Retinal Pigment Epithelium Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 529 - 536. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Brouns, S. Matheson, K. Hu, I Delalle, V. Caviness, J Silver, R. Bronson, and J Settleman The adhesion signaling molecule p190 RhoGAP is required for morphogenetic processes in neural development Development, January 11, 2000; 127(22): 4891 - 4903. [Abstract] [PDF]
|
|
|
|
|
|
C.-H. Heldin and B. Westermark Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor Physiol Rev, October 1, 1999; 79(4): 1283 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Frennesson and S E G Nilsson Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications Br. J. Ophthalmol., October 1, 1998; 82(10): 1169 - 1174. [Abstract] [Full Text]
|
|
|
|
|
|
H. Ozaki, N. Okamoto, S. Ortega, M. Chang, K. Ozaki, S. Sadda, M. A. Vinores, N. Derevjanik, D. J. Zack, C. Basilico, et al. Basic Fibroblast Growth Factor Is Neither Necessary nor Sufficient for the Development of Retinal Neovascularization Am. J. Pathol., September 1, 1998; 153(3): 757 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Mietz, P. Chévez-Barrios, R. M Feldman, and M. W Lieberman Suramin inhibits wound healing following filtering procedures for glaucoma Br. J. Ophthalmol., July 1, 1998; 82(7): 816 - 820. [Abstract] [Full Text]
|
|
|
|
|
|
D. G CHARTERIS Growth factors in proliferative vitreoretinopathy Br. J. Ophthalmol., February 1, 1998; 82(2): 106 - 106. [Full Text]
|
|
|
|
|
|
L Cassidy, P Barry, C Shaw, M J Duffy, and S Kennedy Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders Br. J. Ophthalmol., February 1, 1998; 82(2): 181 - 185. [Abstract] [Full Text]
|
|
|
|
|
|
Y.-S. Chen, S. F Hackett, C.-L. Schoenfeld, M. A Vinores, S. A Vinores, and P. A Campochiaro Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes Br. J. Ophthalmol., October 1, 1997; 81(10): 919 - 926. [Abstract] [Full Text] [PDF]
|
|
